Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLCs registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BAXTER TO AUGMENT INFUSION PUMP OFFERINGS

This article was originally published in The Gray Sheet

Executive Summary

BAXTER TO AUGMENT INFUSION PUMP OFFERINGS via the acquisition of Bard MedSystems. On Feb. 10, Bard announced it had reached an agreement in principle to sell the North Reading, Massachusetts- based division to Baxter. Terms of the agreement were not disclosed. Baxter says that one of the most important products it would pick up through the acquisition is Bard MedSystems' hospital-based patient controlled analgesia pump. The electrically driven pump will complement Baxter's portable PCA patient controlled analgesia device, which is powered by an elastic balloon and can also be used for delivering antibiotics and chemotherapy agents. Other products that Baxter would gain through the deal include an anesthesia delivery product line. Baxter says that MedSystems would continue to be based in North Reading following the acquisition. The firm has not yet determined whether it would make any management, personnel or facility changes. In announcing the deal, Bard said that the sale of MedSystems was in keeping with a company "effort to focus and concentrate its resources on single patient use devices." The transaction is expected to be completed before the end of the first quarter of 1993 and is subject to, among other things, approval by the Department of Justice. Bard says the sale will result in a one-time gain in non-operating income, but since the firm plans "to take a first quarter charge for the adoption of a new accounting standard regarding postretirement benefit obligations," non-operating items "should have no significant effect on first quarter 1993 income."
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT000183

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel